Who owns NEUROONE MEDICAL TECHNOLOGIES Corp?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of NMTC from SEC Form 13F filings across 22 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 22 institutions disclosed 1.6M shares of NEUROONE MEDICAL TECHNOLOGIES Corp worth $1.6M — about 18.4% of shares outstanding; the largest disclosed holder is Bleichroeder LP. Source: SEC Form 13F filings, parsed by EvidInvest.
22
13F holders
$1.6M
value, 2026 filers
18.4%
of shares outstanding (1.6M sh)
5
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of NMTC's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Bleichroeder LP | 666,666 | $686,666 | 0.1% | 7.7% | 0.0% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 352,150 | $362,715 | 0.0% | 4.1% | -0.2% |
| 3 | PERKINS CAPITAL MANAGEMENT INC | 159,854 | $164,650 | 0.1% | 1.8% | -34.7% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 93,555 | $96,374 | 0.0% | 1.1% | 0.0% |
| 5 | Sio Capital Management, LLC | 82,767 | $85,250 | 0.0% | 1% | 0.0% |
| 6 | VANGUARD FIDUCIARY TRUST CO | 49,018 | $50,489 | 0.0% | 0.6% | 0.0% |
| 7 | STATE STREET CORPNEW | 43,015 | $44,305 | 0.0% | 0.5% | new |
| 8 | Cambridge Investment Research Advisors, Inc. | 28,715 | $30,000 | 0.0% | 0.3% | +0.8% |
| 9 | BlackRock, Inc. | 24,029 | $24,750 | 0.0% | 0.3% | -4.3% |
| 10 | NORTHERN TRUST CORP | 21,398 | $22,040 | 0.0% | 0.2% | 0.0% |
| 11 | TWO SIGMA SECURITIES, LLCNEW | 19,881 | $20,477 | 0.0% | 0.2% | new |
| 12 | BARCLAYS PLC | 18,757 | $19,320 | 0.0% | 0.2% | +24580.3% |
| 13 | UBS Group AG | 14,264 | $14,692 | 0.0% | 0.2% | +443.8% |
| 14 | Belpointe Asset Management LLC | 12,500 | $12,875 | 0.0% | 0.1% | 0.0% |
| 15 | MORGAN STANLEY | 1,835 | $1,890 | 0.0% | 0% | -10.8% |
| 16 | Tower Research Capital LLC (TRC) | 1,283 | $1,321 | 0.0% | 0% | +1045.5% |
| 17 | GK Wealth Management LLCNEW | 692 | $713 | 0.0% | 0% | new |
| 18 | ROYAL BANK OF CANADANEW | 312 | $0 | 0.0% | 0% | new |
| 19 | WELLS FARGO & COMPANY/MN | 166 | $171 | 0.0% | 0% | 0.0% |
| 20 | JPMORGAN CHASE & CONEW | 88 | $96 | 0.0% | 0% | new |
| 21 | OSAIC HOLDINGS, INC. | 58 | $59 | 0.0% | 0% | 0.0% |
| 22 | SBI Securities Co., Ltd. | 13 | $13 | 0.0% | 0% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.